Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer.
Anton A, Kamel Hasan O, Ballok Z, Bowden P, Costello AJ, Harewood L, Corcoran NM, Dundee P, Peters JS, Lawrentschuk N, Troy A, Webb D, Chan Y, See A, Siva S, Murphy D, Hofman MS, Tran B.
Anton A, et al. Among authors: ballok z.
BJU Int. 2020 Oct;126(4):433-435. doi: 10.1111/bju.15151. Epub 2020 Aug 4.
BJU Int. 2020.
PMID: 32579772
No abstract available.